PharmaShots | Incisive News in 3 Shots

Subscribe Now

us fda

Insights+: The US FDA New Drug Approvals in June 2024

Insights+: The US FDA New Drug Approvals in June 2024

July 16, 2024

New Drug Designations - April 2024

New Drug Designations - April 2024

May 30, 2024

New Drug Designations - March 2024

New Drug Designations - March 2024

April 30, 2024

The US FDA is Set to Establish a New Advisory Committee for Evaluating Genetic Metabolic Disease Treatments

The US FDA is Set to Establish a New Advisory Committee for Evaluating Genetic Metabolic Disease Treatments

December 14, 2023

Insights+: The US FDA New Drug Approvals in October 2022

Insights+: The US FDA New Drug Approvals in October 2022

November 17, 2022

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as an Adjuvant Therapy for Renal Cell Carcinoma

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as an Adjuvant Therapy for Renal Cell Carcinoma

November 19, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us